National Institute on Aging logo
Research on Current Topics in AD/ADRD

NIA AD/ADRD R21 Exploratory Research Grant

Supports exploratory Alzheimer's and dementia studies in the United States for high-risk, novel research directions.

DiscontinuedNational Institute on AgingUnited States
View on funder site
About

PAR-25-331, titled Research on Current Topics in Alzheimer's Disease and AD-Related Dementias (R21 Clinical Trial Optional), is NIA's parent NOFO for exploratory and developmental R21 grants in the AD/ADRD space. The R21 mechanism supports up to two years of high-risk, novel research that is not yet ready for the longer commitment of an R01. Released December 30, 2024 and expiring November 17, 202…

What this grant funds

Exploratory and developmental research on current priority topics in Alzheimer's disease and related dementias, as defined by active NOSIs attached to PAR-25-331.

Key facts
CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.17 Nov 2027
Decision timeiTypical time from the deadline to the funder's decision.—
Project durationiHow long the funded work is expected to run.—
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.—
Funding analytics

Sign up free to see the funding breakdown

Create free accountSign in
Industries

Sign up free to see the industries in scope

Create free accountSign in
Eligibility criteria

Sign up free to see the full eligibility

Create free accountSign in
Application process

Sign up free to see how to apply

Create free accountSign in
Timeline

Sign up free to see the timeline

Create free accountSign in
Last verified: 24 Jul 2026Source: www.nia.nih.gov